Retraction: Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and bax and inhibition of the PI3K/Akt pathway in gliomas (PLoS ONE (2010) 5:10 (e13731) DOI: 10.1371/journal.pone.0013731);Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Malla, Ramarao ^a   Gopinath, Sreelatha ^a   Alapati, Kiranmai ^a   Gondi, Christopher S ^a   Gujrati, Meena ^a   Dinh, Dzung H ^a   Mohanam, Sanjeeva ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; CATHEPSIN B; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; UROKINASE; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME INHIBITION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; BRAIN TUMOR; GENETICS; GLIOBLASTOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

MUS MUSCULUS;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BRAIN NEOPLASMS; CATHEPSIN B; CELL LINE, TUMOR; DOWN-REGULATION; GLIOBLASTOMA; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION;

EID: 78149447767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0228688     Document Type: Erratum

References (63)

1. Huppertz B, Frank HG, Kaufmann P (1999) The apoptosis cascade- morphological and immunohistochemical methods for its visualization. Anat Embryol (Berl) 200: 1-18.
2. Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306.
3. Giovannini C, Scazzocchio B, Vari R, Santangelo C, D'Archivio M, et al. (2007) Apoptosis in cancer and atherosclerosis: polyphenol activities. Ann Ist Super Sanita 43: 406-416.
4. Ishizaki Y, Cheng L, Mudge AW, Raff MC (1995) Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol Biol Cell 6: 1443-1458.
5. Mayer B, Oberbauer R (2003) Mitochondrial regulation of apoptosis. News Physiol Sci 18: 89-94.: 89-94.
6. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309-1312.
7. Adams JM, Cory S (2001) Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61-66.
8. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326.
9. Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911.
10. Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6: 513-519.
11. Vander Heiden MG, Thompson CB (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1: E209-E216.
12. Martin S, Toquet C, Oliver L, Cartron PF, Perrin P, et al. (2001) Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal. J Neurooncol 52: 129-139.
13. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619.
14. Creson TK, Yuan P, Manji HK, Chen G (2009) Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate. J Mol Neurosci 37: 123-134.
15. Datta SR, Dudek H, Tao X, Masters S, Fu H, et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
16. Du K, Montminy M (1998) CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273: 32377-32379.
17. Kane LP, Shapiro VS, Stokoe D, Weiss A (1999) Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 9: 601-604.
18. Tsuruta F, Masuyama N, Gotoh Y (2002) The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem 277: 14040-14047.
19. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, et al. (1997) CREB: a major mediator of neuronal neurotrophin responses. Neuron 19: 1031-1047.
20. Meller R, Minami M, Cameron JA, Impey S, Chen D, et al. (2005) CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 25: 234-246.
21. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286: 2358-2361.
22. Lonze BE, Riccio A, Cohen S, Ginty DD (2002) Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 34: 371-385.
23. Lademann U, Cain K, Gyrd-Hansen M, Brown D, Peters D, et al. (2003) Diarylurea compounds inhibit caspase activation by preventing the formation of the active 700-kilodalton apoptosome complex. Mol Cell Biol 23: 7829-7837.
24. Fuhrman B, Gantman A, Khateeb J, Volkova N, Horke S, et al. (2009) Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/ MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta. Cardiovasc Res 84: 145-154.
25. Wilson BE, Mochon E, Boxer LM (1996) Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 16: 5546-5556.
26. Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ (1995) Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am J Pathol 146: 1150-1160.
27. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, et al. (1993) Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53: 4143-4147.
28. Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Yamamoto M, et al. (1995) Overexpression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metastasis 13: 49-56.
29. Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, et al. (1994) Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 54: 5016-5020.
30. Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, et al. (2004) RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene 23: 8486-8496.
31. Cregan SP, Dawson VL, Slack RS (2004) Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23: 2785-2796.
32. Brunelle JK, Letai A (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122: 437-441.
33. Steinbach JP, Weller M (2004) Apoptosis in gliomas: molecular mechanisms and therapeutic implications. J Neurooncol 70: 245-254.
34. Korsmeyer SJ (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59: 1693s-1700s.
35. Reed JC (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941-2953.
36. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387: 773-776.
37. Gondi CS, Kandhukuri N, Kondraganti S, Gujrati M, Olivero WC, et al. (2006) RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells. Mol Cancer Ther 5: 3197-3208.
38. Kin Y, Chintala SK, Go Y, Sawaya R, Mohanam S, et al. (2000) A novel role for the urokinase-type plasminogen activator receptor in apoptosis of malignant gliomas. Int J Oncol 17: 61-65.
39. Hajra KM, Liu JR (2004) Apoptosome dysfunction in human cancer. Apoptosis 9: 691-704.
40. Gondi CS, Talluri L, Dinh DH, Gujrati M, Rao JS (2009) RNAi-mediated downregulation of MMP-2 activates the extrinsic apoptotic pathway in human glioma xenograft cells. Int J Oncol 35: 851-859.
41. Cho SG, Choi EJ (2002) Apoptotic signaling pathways: caspases and stress-activated protein kinases. J Biochem Mol Biol 35: 24-27.
42. Shih CM, Wu JS, Ko WC, Wang LF, Wei YH, et al. (2003) Mitochondria-mediated caspase-independent apoptosis induced by cadmium in normal human lung cells. J Cell Biochem 89: 335-347.
43. Lee TJ, Kim EJ, Kim S, Jung EM, Park JW, et al. (2006) Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol Cancer Ther 5: 2398-2407.
44. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656.
45. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3: 489-501.
46. Kiyan J, Kiyan R, Haller H, Dumler I (2005) Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. EMBO J 24: 1787-1797.
47. Duronio V (2008) The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 415: 333-344.
48. Andrisani OM (1999) CREB-mediated transcriptional control. Crit Rev Eukaryot Gene Expr 9: 19-32.
49. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, et al. (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275: 10761-10766.
50. Finkbeiner S (2000) CREB couples neurotrophin signals to survival messages. Neuron 25: 11-14.
51. Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, et al. (1999) Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J Biol Chem 274: 27529-27535.
52. Montminy MR, Bilezikjian LM (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328: 175-178.
53. Gondi CS, Lakka SS, Dinh D, Olivero W, Gujrati M, et al. (2004) Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biology 1: 165-176.
54. Gopinath S, Malla RR, Gondi CS, Alapati K, Fassett D, et al. (2010) Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation. PLoS One 5: e11668.
55. Nalla AK, Gorantla B, Gondi CS, Lakka SS, Rao JS (2010) Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Ther 17: 599-613.
56. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112: 3-25.
57. Mohamed MM, Sloane BF (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6: 764-775.
58. Dasari VR, Veeravalli KK, Saving KL, Gujrati M, Klopfenstein JD, et al. (2008) Neuroprotection by cord blood stem cells against glutamate-induced apoptosis is mediated by Akt pathway. Neurobiol Dis 32: 486-498.
59. Gopinath S, Vanamala SK, Gujrati M, Klopfenstein JD, Dinh DH, et al. (2009) Doxorubicin-mediated apoptosis in glioma cells requires NFAT3. Cell Mol Life Sci 66: 3967-3978.
60. Wijsman JH, Jonker RR, Keijzer R, van d, V, Cornelisse CJ, et al. (1993) A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 41: 7-12.
61. Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, et al. (2007) Intraperitoneal injection of an hpRNA-expressing plasmid targeting uPAR and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice. Clin Cancer Res 13: 4051-4060.
62. Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, et al. (2004) Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23: 4681-4689.
63. Gong J, Traganos F, Darzynkiewicz Z (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218: 314-319.